A carregar...
Polyomavirus-driven Merkel cell carcinoma: prospects for therapeutic vaccine development
Great strides have been made in cancer immunotherapy including the breakthrough successes of anti-PD-(L)1 checkpoint inhibitors. In Merkel cell carcinoma (MCC), a rare and aggressive skin cancer, PD-(L)1 blockade is highly effective. Yet, ~50% of patients either do not respond to therapy or develop...
Na minha lista:
| Publicado no: | Mol Carcinog |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238237/ https://ncbi.nlm.nih.gov/pubmed/32219902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.23190 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|